Nucleus Expands Radiopharmaceutical Capacity to Tackle Supply Issues
Nucleus expands facilities to boost radiopharmaceutical production and ease supply chain issues.
Nucleus RadioPharma is expanding its capabilities in radiopharmaceutical research and manufacturing by establishing two new facilities in Arizona and Pennsylvania. This move is designed to tackle current nationwide supply chain constraints in the industry, improving access to critical radiopharmaceuticals used in cancer treatment and diagnostics.
The facilities will collectively span over 100,000 square feet and aim to bolster production for clinical trials and commercial distribution. Nucleus RadioPharma's partnerships with leading institutions like Mayo Clinic and Fox Chase Cancer Center are key to advancing this growth.
This expansion will create jobs and enhance regional healthcare infrastructure, addressing urgent demand for life-saving radiopharmaceuticals while supporting local economies.
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
Más de Pharma News
Todos los artículos →
Curia New York recibe una carta de advertencia de la FDA por miles de inyecciones cromatográficas no documentadas
Ab Science revisa los cronogramas de los ensayos tras tres inspecciones GCP
Discussion